AABB Congressional Briefing to Highlight Blood Donation and Biotherapies
January 14, 2025
AABB will host a congressional briefing on Jan. 28 to educate policymakers on the importance of the blood supply and spotlight critical issues and opportunities in blood banking, transfusion medicine and biotherapies.
The briefing, "Advancing Blood, Transfusion Medicine and Biotherapies: From Donor to Patient. From Lab to Bedside,” will take place from 1:30 to 2:45 p.m. at the Rayburn House Office Building (Room 2168) in Washington, D.C.
This event will feature AABB leaders and expert voices in the field:
- Debra BenAvram, FASAE, CAE, chief executive officer, AABB.
- AABB President Meghan Delaney, DO, MPH, chief, division of pathology & laboratory medicine, Children’s National Hospital.
- Nancy Dunbar, MD, medical director, blood bank and special coagulation laboratory, Dartmouth-Hitchcock Medical Center.
- Delisa English, MBA, chief executive officer, The Blood Connection.
- Ray Goodrich, PhD, professor, Colorado State University.
- John Hagins, chief executive officer, The Community Blood Center.
- Pampee Young, MD, PhD, chief medical and scientific officer, American Red Cross.
Speakers will explore pressing topics like raising awareness of blood donation, maintaining a resilient blood supply, the role of laboratories in transfusion medicine and advancing research, and innovation in biotherapies.
AABB encourages members to invite their elected officials to attend this important briefing. This event provides a unique opportunity to advocate for legislative solutions that support a sustainable blood supply and improve patient care.
